ACTIVATION OF THE NUCLEAR RECEPTOR PXR DECREASES PLASMA LDL-CHOLESTEROL LEVELS AND INDUCES HEPATIC STEATOSIS IN LDL RECEPTOR KNOCKOUT MICE

被引：0
|
作者：
Hoekstra, M. [1 ]
Lammers, B. [1 ]
Out, R. [1 ]
Li, Z. [1 ]
van Eck, M. [1 ]
van Berkel, T. [1 ]
机构：
[1] Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Activation of the Nuclear Receptor PXR Decreases Plasma LDL-Cholesterol Levels and Induces Hepatic Steatosis in LDL Receptor Knockout Mice
    Hoekstra, Menno
    Lammers, Bart
    Out, Ruud
    Li, Zhaosha
    Van Eck, Miranda
    Van Berkel, Theo J. C.
    [J]. MOLECULAR PHARMACEUTICS, 2009, 6 (01) : 182 - 189
  • [2] FXR Activation By Obeticholic Acid Reduces Plasma LDL-Cholesterol in Mice By Upregulating Hepatic LDL Receptor Via a Posttranscriptional Mechanism
    Liu, Jingwen
    Kraemer, Fredric B.
    Xu, Yanyong
    Zhang, Yanqiao
    Liu, Jingwen
    Singh, Amar
    [J]. HEPATOLOGY, 2018, 68 : 877A - 877A
  • [3] ACTIVATION OF THE CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) DECREASES PLASMA TRIGLYCERIDES AND LDL CHOLESTEROL LEVELS AND REDUCES ATHEROSCLEROTIC LESIONS IN LDL RECEPTOR-DEFICIENT MICE
    Sberna, A. L.
    Assem, M.
    Lagrost, L.
    Masson, D.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [4] Baseline levels of LDL-cholesterol and lipoprotein(A) and the Ava II polymorphism of the LDL receptor gene influence the response of LDL-cholesterol to pravastatin treatment
    Lahoz, M
    Pena, R
    Mostaza, JM
    Laguna, F
    Garcia-Iglesias, MF
    Taboada, K
    Pinto, X
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 21 - 21
  • [5] Activation of PPAR induces hepatic LDL receptor expression
    Han, J.
    Huang, Z.
    He, W.
    Zhou, X.
    Nicholson, A. C.
    Gotto, A. M., Jr.
    Hajjar, D. P.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 331 - 331
  • [6] Preventive exercise decreases cholesterol and modifies atherosclerotic plaque phenotype in LDL receptor knockout mice
    Cardinot, T. M.
    Moretti, A. I.
    Koike, M. K.
    Wanschel, A. C.
    Krieger, M. H.
    Nunes, V. S.
    Cazita, P. M.
    Brum, P. C.
    Souza, H. P.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 74 - 74
  • [7] Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
    Subramanian, Savitha
    Goodspeed, Leela
    Wang, Shari
    Kim, Jinkyu
    Zeng, Lixia
    Ioannou, George N.
    Haigh, W. Geoffrey
    Yeh, Matthew M.
    Kowdley, Kris V.
    O'Brien, Kevin D.
    Pennathur, Subramaniam
    Chait, Alan
    [J]. JOURNAL OF LIPID RESEARCH, 2011, 52 (09) : 1626 - 1635
  • [8] Effects of cholesterol and naringin supplementation cholesterol and hepatic antioxidant enzyme activities in LDL receptor-knockout mice
    Kim, HJ
    Oh, GT
    Jeong, TS
    Park, YB
    Choi, MS
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 282 - 282
  • [9] Dietary iron elevates LDL-cholesterol and decreases plasma antioxidant levels: Influence of antioxidants
    Pool, GF
    van Jaarsveld, H
    [J]. RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1998, 100 (02) : 139 - 150
  • [10] Myeloid cells regulate plasma LDL-cholesterol levels
    Bazioti, Venetia
    La Rose, Anouk M.
    Westerterp, Marit
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (03) : 233 - 239
12345